The potential effect of statins on rituximab immunotherapy

被引：6

作者：

Cragg, Mark S. ^{[1
]}

机构：

[1] Univ Southampton, Canc Sci Div, Southampton, Hants, England

来源：

PLOS MEDICINE | 2008年 / 5卷 / 03期

关键词：

D O I：

10.1371/journal.pmed.0050077

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：356 / 358

页数：3

相关论文

共 28 条

[1]

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction [J].

Byrd, JC ;

Kitada, S ;

Flinn, IW ;

Aron, JL ;

Pearson, M ;

Lucas, N ;

Reed, JC .

BLOOD, 2002, 99 (03) :1038-1043

[2]

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].

Cartron, G ;

Dacheux, L ;

Salles, G ;

Solal-Celigny, P ;

Bardos, P ;

Colombat, P ;

Watier, H .

BLOOD, 2002, 99 (03) :754-758

[3]

Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].

Clynes, RA ;

Towers, TL ;

Presta, LG ;

Ravetch, JV .

NATURE MEDICINE, 2000, 6 (04) :443-446

[4]

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[5]

Cragg Mark S., 2005, V8, P140

[6]

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts [J].

Cragg, MS ;

Morgan, SM ;

Chan, HTC ;

Morgan, BP ;

Filatov, AV ;

Johnson, PWM ;

French, RR ;

Glennie, MJ .

BLOOD, 2003, 101 (03) :1045-1052

[7]

Complement activation determines the therapeutic activity of rituximab in vivo [J].

Di Gaetano, N ;

Cittera, E ;

Nota, R ;

Vecchi, A ;

Grieco, V ;

Scanziani, E ;

Botto, M ;

Introna, M ;

Golay, J .

JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1581-1587

[8]

B-cell targeting in rheumatoid arthritis and other autoimmune diseases [J].

Edwards, JCW ;

Cambridge, G .

NATURE REVIEWS IMMUNOLOGY, 2006, 6 (05) :394-403

[9]

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[10]

ENDO A, 1992, J LIPID RES, V33, P1569